I am not sure what you mean.. their statics are sound. p values indicated significant change. They used proper tests for comparative statics and did not draw conclusions from insignificant results.
There is really nothing else one could desire from a phase II trial. Phase III should be interesting and on track due to the lack of potential adverse reactions propagated from the mechanism of action.